What patents tell us about drug repurposing for cancer: A landscape analysis.

Abstract:

:Intellectual property documents (patents and their published applications) are not only collections of legal exclusivity claims but also repositories of scientific and technical information, even though they are not peer reviewed. We have identified and analyzed international disclosures concerning drug repurposing for cancer that were published under the Patent Convention Treaty during the past five years, and show this burgeoning field from an angle that is not routinely captured in review papers of the field. We find that patenting activity for cancer-related new uses for known compounds has been quite constant recently and has targeted mainly small molecule active ingredients that are currently marketed as drugs. Universities contributed most applications, closely followed by corporations. The strong representation of non-academic research institutes from the public and private sector and foundations was surprising and indicates that drug repurposing for cancer has transcended the classical corporate-academia dichotomy. Many of the identified patent documents report findings that are not reflected in the peer review literature (e.g., sumatriptan for mycosis fungoides) or appear there only later (e.g., ibudilast for glioblastoma). Synergistic combinations of several repurposed compounds were also identified, as were two documents related to the repurposing of vaccines. Our findings underscore the necessity for drug repurposers as well as for oncologists to investigate patent documents in addition to the usual peer review literature search to obtain a comprehensive perspective of the state of the art.

journal_name

Semin Cancer Biol

authors

Mucke HAM

doi

10.1016/j.semcancer.2019.09.010

subject

Has Abstract

pub_date

2019-09-20 00:00:00

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(19)30281-0

pub_type

杂志文章,评审
  • Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to anticancer treatment.

    abstract::While tumours arise from acquired mutations in oncogenes or tumour-suppressor genes, it is clearly established that cancers are metabolic diseases characterized by metabolic alterations in tumour cells, and also non-tumour cells of the host organism resulting in tumour cachexia and patient weakness. In this review, we...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.03.004

    authors: Dumas JF,Brisson L,Chevalier S,Mahéo K,Fromont G,Moussata D,Besson P,Roger S

    更新日期:2017-04-01 00:00:00

  • KSHV strains: the origins and global spread of the virus.

    abstract::Nucleotide sequence analysis at five distinct loci across the 140, 000 bp genomes of more than 60 KSHV samples from KS and PEL tumors from North America, Africa, the Middle East, Asia and the Pacific revealed that they cluster into four major subtypes (A, B, C and D) that have close associations with the geographic an...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1998.0116

    authors: Hayward GS

    更新日期:1999-06-01 00:00:00

  • Definition of tumor antigens suitable for vaccine construction.

    abstract::The treatment of cancer with tumor vaccines has been a goal of physicians and scientists ever since effective immunization against infectious disease with vaccines was developed. In the past, major tumor antigens had not been molecularly characterized. Recent advances are, however, beginning to define potential molecu...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/1044-579x(95)90001-2

    authors: Lewis JJ,Houghton AN

    更新日期:1995-12-01 00:00:00

  • Aberrations in DNA repair pathways in cancer and therapeutic significances.

    abstract::Cancer cells show various types of mutations and aberrant expression in genes involved in DNA repair responses. These alterations induce genome instability and promote carcinogenesis steps and cancer progression processes. These defects in DNA repair have also been considered as suitable targets for cancer therapies. ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.02.005

    authors: Motegi A,Masutani M,Yoshioka KI,Bessho T

    更新日期:2019-10-01 00:00:00

  • Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy.

    abstract::The need for more effective cancer therapies is omnipresent as the ever-complex, and highly adaptive, mechanisms of tumor biology allow this disease to elude even the most stringent treatment options. The expanding field of proteoglycan signaling is enticing as a reservoir of potential drug targets and prospects for n...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.05.003

    authors: Gubbiotti MA,Buraschi S,Kapoor A,Iozzo RV

    更新日期:2020-05-01 00:00:00

  • Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.

    abstract::Prostate cancer (PCa), a hormonally-driven cancer, ranks first in incidence and second in cancer related mortality in men in most Western industrialized countries. Androgen and androgen receptor (AR) are the dominant modulators of PCa growth. Over the last two decades multiple advancements in screening, treatment, sur...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2016.06.003

    authors: Kallifatidis G,Hoy JJ,Lokeshwar BL

    更新日期:2016-10-01 00:00:00

  • Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma.

    abstract::Diffuse large B cell lymphoma (DLBCL) is the most common form of B cell non-Hodgkin lymphoma worldwide and comprises a heterogeneous group of malignancies that originate from the malignant transformation of germinal center (GC) B cells. Over the past decade, significant improvement has been achieved in our understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2016.08.001

    authors: Pasqualucci L,Zhang B

    更新日期:2016-08-01 00:00:00

  • Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy.

    abstract::Angiogenesis plays a pivotal role in cancer progression and is required for tissue invasion and metastasis. Starting with Folkman's initial observations in 1971, basic research continued to shed new molecular insight into this multifaceted process, leading to the development of several anti-angiogenic drugs. To date, ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.11.005

    authors: Ricciuti B,Foglietta J,Bianconi V,Sahebkar A,Pirro M

    更新日期:2019-06-01 00:00:00

  • Microenvironment and HIV-related lymphomagenesis.

    abstract::Patients with HIV infection are at increased risk of developing non-Hodgkin lymphoma and Hodgkin lymphoma. While the pathogenesis of these lymphomas is incompletely understood, evidence indicates that immune deregulation, genetic alterations and cytokine production play an important role in HIV lymphomagenesis. The ly...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2015.06.002

    authors: Pantanowitz L,Carbone A,Dolcetti R

    更新日期:2015-10-01 00:00:00

  • Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.

    abstract::Cancer, being the most prevalent and resistant disease afflicting any gender, age or social status, is the ultimate challenge for the scientific community. The new generation therapeutics for cancer management has shifted the approach to personalized/precision medicine, making use of patient- and tumor-specific marker...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.08.023

    authors: Zafar S,Beg S,Panda SK,Rahman M,Alharbi KS,Jain GK,Ahmad FJ

    更新日期:2019-08-20 00:00:00

  • Intracellular signaling by cathepsin X: molecular mechanisms and diagnostic and therapeutic opportunities in cancer.

    abstract::Cathepsin X is a cysteine carboxypeptidase, localized predominantly in immune cells, regulating their proliferation, maturation, migration and adhesion. It has recently been confirmed as a significant promoter of malignant progression. Its role in signal transduction was first implied through the interaction with inte...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2014.05.001

    authors: Kos J,Vižin T,Fonović UP,Pišlar A

    更新日期:2015-04-01 00:00:00

  • The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?

    abstract::Neutrophils in the tumor host may promote tumor progression by enhancing angiogenesis, invasion and metastasis. Granulocytic myeloid-derived suppressor cells (MDSC) share many features with neutrophils. Classically, MDSC are viewed as and defined as immunosuppressive cells. In this article we summarize and critically ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.02.007

    authors: Brandau S,Moses K,Lang S

    更新日期:2013-06-01 00:00:00

  • Prostate-specific antigen.

    abstract::Prostate specific antigen (PSA) is serine protease produced at high concentrations by normal and malignant prostatic epithelium. It is mainly secreted into seminal fluid, where it digests the gel forming after ejaculation. Only minor amounts of PSA leak out into circulation from the normal prostate, but the release of...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1998.0086

    authors: Stenman UH,Leinonen J,Zhang WM,Finne P

    更新日期:1999-04-01 00:00:00

  • Repurposing drugs in oncology: From candidate selection to clinical adoption.

    abstract::Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of existing medicines developed in other disease areas. Such a strategy includes the identification of candidate drugs, clinical development, drug licensing, reimbursement and clinical implementation. This review outlines a l...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.01.008

    authors: Pantziarka P,Verbaanderd C,Huys I,Bouche G,Meheus L

    更新日期:2020-01-23 00:00:00

  • Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.

    abstract::In animal models complete and permanent eradication of tumors can be achieved by adoptive transfer of tumor specific T cells, combined with interleukin 2. The most active cells are CD8+ cytotoxic T lymphocytes (CTL), which recognize peptides of 8-10 amino acids in length, bound to the antigen presenting groove of MHC ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Melief CJ,Kast WM

    更新日期:1991-10-01 00:00:00

  • MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

    abstract::The discovery of microRNAs (miRNAs) is one of the major scientific breakthroughs in recent years and has revolutionized the way we look at gene regulation. Although we are still at a very early stage in understanding their impact on immunity, miRNAs are changing the way we think about the development of the immune sys...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.01.005

    authors: Sonkoly E,Ståhle M,Pivarcsi A

    更新日期:2008-04-01 00:00:00

  • Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis.

    abstract::Notch signaling is mediated by cell-cell interactions and is critical for cell fate determination in many species. Recently, a family of mastermind-like (MAML) transcriptional co-activator genes was identified that encode proteins that cooperate with Notch and CSL to activate transcription. Here, we review our current...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2004.04.014

    authors: Wu L,Griffin JD

    更新日期:2004-10-01 00:00:00

  • The genetic analysis of prostate carcinoma.

    abstract::The molecular events underlying prostatic tumorigenesis remain incompletely understood. The application of cytogenetic, molecular genetic and molecular cytogenetic techniques have led to the identification of consistent genetic changes. This paper will discuss these techniques, review the genetic aberrations discovere...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1997.0051

    authors: Roylance R,Spurr N,Sheer D

    更新日期:1997-02-01 00:00:00

  • Bladder cancer, a two phased disease?

    abstract::The processes of intraepithelial migration, intraluminal seeding, and field cancerization as models for initiation, spread, and recurrences of urothelial cell carcinoma (UCC) are reviewed in light of recent molecular investigations. The accumulated molecular data on synchronous and metachronous tumors indicate that th...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2006.02.002

    authors: Höglund M

    更新日期:2007-06-01 00:00:00

  • APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

    abstract::The anaphase promoting complex/ cyclosome (APC/C), is an evolutionarily conserved protein complex essential for cellular division due to its role in regulating the mitotic transition from metaphase to anaphase. In this review, we highlight recent work that has shed light on our understanding of the role of APC/C coact...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.03.001

    authors: Schrock MS,Stromberg BR,Scarberry L,Summers MK

    更新日期:2020-12-01 00:00:00

  • Laminin isoforms in tumor invasion, angiogenesis and metastasis.

    abstract::Laminins are a growing family of alphabetagamma heterotrimeric proteins, commonly found in basement membranes (BMs). These large molecules promote cell adhesion and migration via integrins and other cell-surface receptors. Over 12 laminin isoforms are presently known. The various isoforms have a cell- and tissue-speci...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/S1044-579X(02)00023-8

    authors: Patarroyo M,Tryggvason K,Virtanen I

    更新日期:2002-06-01 00:00:00

  • The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.

    abstract::Natural killer (NK) cells have important functions in the innate immunity to tumors. Recognition of tumor cells by NK cells is mediated by the interaction of activating and inhibitory NK cell receptors with ligands expressed on the tumor target. In addition, NK cell-target cell interactions require the engagement of a...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2006.07.002

    authors: Fuchs A,Colonna M

    更新日期:2006-10-01 00:00:00

  • Uveal melanoma pathobiology: Metastasis to the liver.

    abstract::Uveal melanoma (UM) is a type of intraocular tumor with a propensity to disseminate to the liver. Despite the identification of the early driver mutations during the development of the pathology, the process of UM metastasis is still not fully comprehended. A better understanding of the genetic, molecular, and environ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.05.003

    authors: Bustamante P,Piquet L,Landreville S,Burnier JV

    更新日期:2020-05-22 00:00:00

  • ER stress and hexosamine pathway during tumourigenesis: A pas de deux?

    abstract::Both the hexosamine biosynthetic pathway (HBP) and the endoplasmic reticulum (ER) are considered sensors for the nutritional state of the cell. The former is a branch of the glucose metabolic pathway that provides donor molecules for glycosylation processes, whereas the second requires co-translational N-glycosylation...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2015.04.001

    authors: Vasseur S,Manié SN

    更新日期:2015-08-01 00:00:00

  • The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives.

    abstract::Breast cancer (BC) cell de-sensitization to Tamoxifen (TAM) or other selective estrogen receptor (ER) modulators (SERM) is a complex process associated with BC heterogeneity and the transformation of ER signalling. The most influential resistance-related mechanisms include modifications in ER expression and gene regul...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.12.004

    authors: Sukocheva OA,Lukina E,Friedemann M,Menschikowski M,Hagelgans A,Aliev G

    更新日期:2020-12-07 00:00:00

  • Spatial genome organization in the formation of chromosomal translocations.

    abstract::Chromosomal translocations and genomic instability are universal hallmarks of tumor cells. While the molecular mechanisms leading to the formation of translocations are rapidly being elucidated, a cell biological understanding of how chromosomes undergo translocations in the context of the cell nucleus in vivo is larg...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2006.10.008

    authors: Meaburn KJ,Misteli T,Soutoglou E

    更新日期:2007-02-01 00:00:00

  • Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.

    abstract::Colorectal cancer (CRC) is one of the leading causes of cancer related-deaths. The risk of development of CRC is complex and multifactorial, and includes disruption of homeostasis of the intestinal epithelial layer mediated though dysregulations of tumor suppressing/promoting signaling pathways. Guanylate cyclase 2C (...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.08.011

    authors: Yarla NS,Gali H,Pathuri G,Smriti S,Farooqui M,Panneerselvam J,Kumar G,Madka V,Rao CV

    更新日期:2019-06-01 00:00:00

  • Mitochondrial ribosomes in cancer.

    abstract::Mitochondria play fundamental roles in the regulation of life and death of eukaryotic cells. They mediate aerobic energy conversion through the oxidative phosphorylation (OXPHOS) system, and harbor and control the intrinsic pathway of apoptosis. As a descendant of a bacterial endosymbiont, mitochondria retain a vestig...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.04.004

    authors: Kim HJ,Maiti P,Barrientos A

    更新日期:2017-12-01 00:00:00

  • The mitochondrial dynamics in cancer and immune-surveillance.

    abstract::Mitochondria-shaping proteins control the dynamic equilibrium between fusion and fission of the mitochondrial network. Their balance is strictly required to regulate various processes, including the quality of mitochondria, cell metabolism, cell death, proliferation and cell migration. Alterations in these processes a...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.06.007

    authors: Simula L,Nazio F,Campello S

    更新日期:2017-12-01 00:00:00

  • Extracellular RNA mediates and marks cancer progression.

    abstract::Different types of RNAs identified thus far represent a diverse group of macromolecules that are involved in the regulation of different biological processes. RNA is generally thought to be localized primarily in the nucleus and cytoplasm; however, some types of RNA have been detected in the extracellular milieu. Thes...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2014.04.010

    authors: Redzic JS,Balaj L,van der Vos KE,Breakefield XO

    更新日期:2014-10-01 00:00:00